Related Experiment Video
Updated: Jan 8, 2026

07:14
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
15.3K
Subthalamic versus Posterior Subthalamic Stimulation for Optimal Tremor Control in Parkinson's Disease
Gabriele Bellini1,2,3, Vincenzo Daniele Boccia1,2,4, Roberto Ceravolo3
1Department of Neurosurgery, NYU Langone Health, New York, New York, USA.
Stereotactic and Functional Neurosurgery
|December 18, 2025
Summary
Deep Brain Stimulation (DBS) targeting the posterior subthalamic area (PSA) may offer superior tremor suppression for tremor-predominant Parkinson's disease (TPPD) compared to traditional subthalamic nucleus (STN) targeting.
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- Tremor-predominant Parkinson's disease (TPPD) often benefits from Deep Brain Stimulation (DBS).
- Subthalamic nucleus (STN) targeting is standard, but intraoperative results vary.
- Posterior subthalamic area (PSA), including caudal zona incerta (cZI), shows promise for tremor suppression.
Purpose of the Study:
- To compare intraoperative and clinical outcomes of STN versus PSA/cZI targeting for TPPD.
- To evaluate the efficacy of dual trajectory microelectrode recording (MER) in guiding DBS lead placement.
Main Methods:
- Retrospective analysis of 22 TPPD patients undergoing dual trajectory MER targeting STN and PSA/cZI.
- Comparison of neurophysiology and tremor response between central (STN) and posterior (PSA) trajectories.
- Analysis of outcomes for patients receiving STN (16) or PSA/cZI (12) lead implantation.
Main Results:
- Both STN and PSA/cZI DBS provided significant motor improvement.
- Intraoperative test stimulation of the posterior (PSA) trajectory yielded more consistent tremor arrest than the STN.
- Posterior lead placement may enhance tremor suppression without compromising other motor symptoms.
Conclusions:
- Intraoperative physiological feedback is crucial for trajectory selection in TPPD.
- PSA/cZI DBS is an effective, potentially superior target for managing tremor in Parkinson's disease.
- Further research supports PSA/cZI as a key target for TPPD management.
Related Concept Videos
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

